Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world. [electronic resource]
Producer: 20171120Description: 791-798 p. digitalISSN:- 0392-856X
- Adalimumab -- administration & dosage
- Administrative Claims, Healthcare
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- diagnosis
- Biological Products -- administration & dosage
- Cost-Benefit Analysis
- Databases, Factual
- Drug Administration Schedule
- Drug Costs
- Etanercept -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Models, Economic
- Multivariate Analysis
- Retrospective Studies
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.